<DOC>
	<DOCNO>NCT02755974</DOCNO>
	<brief_summary>The London COPD exacerbation ( EXCEL ) cohort build establish cohort start 1995 design study COPD exacerbation impact health-status disease progression .</brief_summary>
	<brief_title>The London COPD Exacerbation Cohort</brief_title>
	<detailed_description>Our intention phenotype Chronic Obstructive Pulmonary Disease ( COPD ) patient basis factor relate ( ) exacerbation frequency include ( b ) lung function ass disease severity , ( c ) baseline therapy , ( ) airway systemic inflammatory marker , ( e ) health status , ( f ) gene expression , ( g ) airway bacterial viral load ( h ) co-morbidity include cardiovascular disease , diabetes psychological disease , ( ) psychological factor , ( j ) mortality , ( k ) nasal susceptibility rhinovirus infection , ( l ) heart rate variability ( ) exhale hydrogen sulphide .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Forced Expiratory Volume 1 sec ( FEV1 ) /Forced Vital Capacity ( FVC ) ratio &lt; 0.70 Able willing give inform write consent Patients history asthma , bronchiectasis , carcinoma bronchus , significant respiratory disease exclude . Patients Immunosuppressive medication active cancer Long term steroid therapy Age &lt; 40 year recruitment</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>